Orbimed Advisors - NABRIVA THERAPEUTICS PLC ownership

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 3 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q3 2020$1,410,000
-55.0%
2,644,600
-43.1%
0.02%
-59.1%
Q2 2020$3,133,000
+17.3%
4,644,6000.0%0.04%
-2.2%
Q1 2020$2,671,000
-56.4%
4,644,6000.0%0.04%
-48.9%
Q4 2019$6,131,000
-34.0%
4,644,6000.0%0.09%
-50.0%
Q3 2019$9,289,000
-17.7%
4,644,6000.0%0.18%
+0.6%
Q2 2019$11,286,000
-0.4%
4,644,6000.0%0.18%0.0%
Q1 2019$11,333,000
+67.1%
4,644,6000.0%0.18%
+40.0%
Q4 2018$6,781,000
-45.9%
4,644,6000.0%0.12%
-17.2%
Q3 2018$12,540,000
-8.1%
4,644,600
+18.5%
0.15%
-7.4%
Q2 2018$13,640,000
-30.8%
3,919,6000.0%0.16%
-33.2%
Q1 2018$19,716,000
-15.9%
3,919,6000.0%0.24%
-17.6%
Q4 2017$23,439,000
-27.0%
3,919,6000.0%0.30%
-3.6%
Q3 2017$32,102,000
-21.8%
3,919,6000.0%0.31%
-28.8%
Q2 2017$41,077,0003,919,6000.43%
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
FIRST NATIONAL CORP /MA/ /ADV 1,000$941,0000.61%
Aisling Capital Management LP 1,910,287$1,098,0000.48%
Values First Advisors, Inc. 410,653$236,1250.28%
FRAZIER MANAGEMENT LLC 4,256,526$2,448,0000.28%
Vivo Capital, LLC 1,704,130$980,0000.09%
SABBY MANAGEMENT, LLC 367,613$211,0000.09%
Orbimed Advisors 4,644,600$2,671,0000.04%
Rock Springs Capital Management LP 1,050,000$604,0000.02%
Clear Creek Financial Management, LLC 112,000$62,0000.02%
EXANE DERIVATIVES 82,078$47,193,0000.01%
View complete list of NABRIVA THERAPEUTICS PLC shareholders